Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting
PHILADELPHIA, June 8, 2022 /PRNewswire/ — Integral Molecular and Optimeos Life Sciences announce a partnership to develop next-generation…